Omega-3 in spotlight
February 20, 2014
Anti-inflammatory agents,
such as acetyl-salicylic acid (ASA),
celecoxib, anti-TNF-α agents,
minocycline, curcumin and
omega-3 fatty acids, are being
investigated for use in mood
disorders summarises some new
Canada and Brazil universities’
research.
Current evidence shows improved
outcomes in mood disorder
patients when anti-inflammatory
agents are used as an adjunct to
conventional therapy; however,
further research is needed to
establish the therapeutic benefit
and appropriate dosage the authors
said.
CLI CK HERE to read the abstract.
MEANWHIL E Omega-3
supplements have also been
demonstrated to improve the
symptoms of dry eye syndrome
reducing the need for eye drops
in three recent studies published
in Clinical Ophthalmology, Clinical
& experimental ophthalmology
and The International Journal of
Ophthalmology.
According to the Optometrists
Association of Australia, it is
estimated that almost half of all
office workers suffer from dry eye
syndrome due to long exposure to
computer screens and a dry, airconditioned
environment.
The above article was sent to subscribers in Pharmacy Daily's issue from 20 Feb 14To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Feb 14
